<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="http://www.loc.gov/MARC21/slim">

  <leader>02995cam a2200349 a 4500</leader>
  <controlfield tag="003">EG-GiCUC</controlfield>
  <controlfield tag="005">20250223031912.0</controlfield>
  <controlfield tag="008">180109s2017    ua dho f m    000 0 eng d</controlfield>
  <datafield tag="040" ind1=" " ind2=" ">
    <subfield code="a">EG-GiCUC</subfield>
    <subfield code="b">eng</subfield>
    <subfield code="c">EG-GiCUC</subfield>
  </datafield>
  <datafield tag="041" ind1="0" ind2=" ">
    <subfield code="a">eng</subfield>
  </datafield>
  <datafield tag="049" ind1=" " ind2=" ">
    <subfield code="a">Deposite </subfield>
  </datafield>
  <datafield tag="097" ind1=" " ind2=" ">
    <subfield code="a">Ph.D</subfield>
  </datafield>
  <datafield tag="099" ind1=" " ind2=" ">
    <subfield code="a">Cai01.24.03.Ph.D.2017.Sh.E</subfield>
  </datafield>
  <datafield tag="100" ind1="0" ind2=" ">
    <subfield code="a">Shimaa Abdelalim Mahmmoud Essa</subfield>
  </datafield>
  <datafield tag="245" ind1="1" ind2="0">
    <subfield code="a">Efficacy of combined use of low intensity laser therapy and ultraviolet radiation in the treatment of relapsing-remitting  multiple sclerosis patients / </subfield>
    <subfield code="c">Shimaa Abdelalim Mahmmoud Essa ; Supervised Yousry Mahmoud Mostafa , Shereen Mohamed Fathi Sheir , Ayatullah Farouk Ahmed</subfield>
  </datafield>
  <datafield tag="246" ind1="1" ind2="5">
    <subfield code="a">&#x641;&#x639;&#x627;&#x644;&#x64A;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x62E;&#x62F;&#x627;&#x645; &#x627;&#x644;&#x645;&#x634;&#x62A;&#x631;&#x643; &#x644;&#x644;&#x64A;&#x632;&#x631; &#x645;&#x646;&#x62E;&#x641;&#x636; &#x627;&#x644;&#x634;&#x62F;&#x629; &#x648;&#x627;&#x644;&#x623;&#x634;&#x639;&#x629; &#x641;&#x648;&#x642; &#x627;&#x644;&#x628;&#x646;&#x641;&#x633;&#x62C;&#x64A;&#x629; &#x641;&#x649; &#x639;&#x644;&#x627;&#x62C; &#x645;&#x631;&#x636;&#x649; &#x627;&#x644;&#x62A;&#x635;&#x644;&#x628; &#x627;&#x644;&#x645;&#x62A;&#x639;&#x62F;&#x62F; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x643;&#x627;&#x633;&#x649;- &#x627;&#x644;&#x625;&#x646;&#x62D;&#x635;&#x627;&#x631;&#x64A; </subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="a">Cairo : </subfield>
    <subfield code="b">Shimaa Abdelalim Mahmmoud Essa , </subfield>
    <subfield code="c">2017</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">141 P. : </subfield>
    <subfield code="b">charts , facsimiles , photographs ; </subfield>
    <subfield code="c">25cm</subfield>
  </datafield>
  <datafield tag="502" ind1=" " ind2=" ">
    <subfield code="a">Thesis (Ph.D.) - Cairo University - National Institute of Laser Enhanced Sciences - Department of Laser Applications in Medicine and Biology</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Background: Multiple sclerosis is an Inflammatory and neurodegenerative disease of the central nervous system of unknown reason or definite cure. Purpose: Proposing safe alternative therapies for the early management of multiple sclerosis. Study Design: Repeated measures randomized control trial. Materials and methods: 24 patients with relapsing-remitting multiple Sclerosis, from both sexes completed the study, age 25-45 years; randomly assigned into four groups. Seven patients in the control group (1); received monthly IV infusion of (1g) Solu-Medrol therapy for multiple sclerosis. Six Patients in group (2) received Solu-Medrol plus low intensity laser therapy LILT 850 nm. Six patients in group (3) received Solu-Medrol plus broad band ultraviolet B radiation BB-UVBR (280-320 nm). Five patients in group (4) received Solu-Medrol, scanner LILT and BB-UVBR; all three groups received sessions 3 days/week for 12 sessions. Expanded disability status Scale (EDSS), Fatigue severity scale (FSS), visual evoked potential (VEP), H-reflex latency, and H/M Ratio were assessed pre-treatment, post treatment, 3 months follow up. Results: Statistically significant reduction of fatigue severity FSS was recorded between the four groups post treatment (p=.013) in favor of group (4) and highly significant one (p=.005) at follow up in favor of the group (3)</subfield>
  </datafield>
  <datafield tag="530" ind1=" " ind2=" ">
    <subfield code="a">Issued also as CD</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2="4">
    <subfield code="a">Broad Band Ultraviolet B Radiation </subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2="4">
    <subfield code="a">Multiple Sclerosis </subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2="4">
    <subfield code="a">Phototherapy </subfield>
  </datafield>
  <datafield tag="700" ind1="0" ind2=" ">
    <subfield code="a">Ayatullah Farouk Ahmed , </subfield>
    <subfield code="e">Supervisor</subfield>
  </datafield>
  <datafield tag="700" ind1="0" ind2=" ">
    <subfield code="a">Shereen Mohamed Fathi Sheir , </subfield>
    <subfield code="e">Supervisor</subfield>
  </datafield>
  <datafield tag="700" ind1="0" ind2=" ">
    <subfield code="a">Yousry Mahmoud Mostafa , </subfield>
    <subfield code="e">Supervisor</subfield>
  </datafield>
  <datafield tag="856" ind1=" " ind2=" ">
    <subfield code="u">http://172.23.153.220/th.pdf</subfield>
  </datafield>
  <datafield tag="905" ind1=" " ind2=" ">
    <subfield code="a">Nazla</subfield>
    <subfield code="e">Revisor</subfield>
  </datafield>
  <datafield tag="905" ind1=" " ind2=" ">
    <subfield code="a">Shimaa</subfield>
    <subfield code="e">Cataloger</subfield>
  </datafield>
  <datafield tag="942" ind1=" " ind2=" ">
    <subfield code="2">ddc</subfield>
    <subfield code="c">TH</subfield>
  </datafield>
  <datafield tag="999" ind1=" " ind2=" ">
    <subfield code="c">64503</subfield>
    <subfield code="d">64503</subfield>
  </datafield>
  <datafield tag="952" ind1=" " ind2=" ">
    <subfield code="2">ddc</subfield>
    <subfield code="7">0</subfield>
    <subfield code="a">CUCL</subfield>
    <subfield code="b">cl210</subfield>
    <subfield code="d">2024-02-11</subfield>
    <subfield code="o">Cai01.24.03.Ph.D.2017.Sh.E</subfield>
    <subfield code="p">01010110074022000</subfield>
    <subfield code="r">2023-09-22 00:00:00</subfield>
    <subfield code="y">TH</subfield>
  </datafield>
  <datafield tag="952" ind1=" " ind2=" ">
    <subfield code="2">ddc</subfield>
    <subfield code="7">0</subfield>
    <subfield code="a">CUCL</subfield>
    <subfield code="b">cl2u8</subfield>
    <subfield code="d">2024-02-11</subfield>
    <subfield code="o">Cai01.24.03.Ph.D.2017.Sh.E</subfield>
    <subfield code="p">01020110074022000</subfield>
    <subfield code="r">2023-09-22 00:00:00</subfield>
    <subfield code="t">74022.CD     </subfield>
    <subfield code="y">CD</subfield>
  </datafield>
</record>
